Back to URGN

Opaleye Management Inc. → URGN

Opaleye Management Inc. URGN Position History

UroGen Pharma Ltd. • Healthcare

Quarters held
5
Latest value
$58.5M
Q3 2026
Peak value
$58.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$6.3M
Q4 2025$6.3M
Q1 2026$25.7M
Q2 2026$53M
Q3 2026$58.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$58.5M1.44M——
Q2 2026$53M1.44M——
Q1 2026$25.7M1.43M——
Q4 2025$6.3M268.4K——
Q4 2025$6.3M268.4K——

Other funds holding URGN

Other Opaleye Management Inc. positions

LQDA

LIQUIDIA CORPORATION

$195.1M
HROW

HARROW HEALTH INC

$191.3M
HROW

HARROW HEALTH INC

$191.3M
ETON

ETON PHARMACEUTICALS INC

$125.6M
ETON

ETON PHARMACEUTICALS INC

$103.5M
HROW

HARROW INC

$101.9M
HROW

HARROW INC

$99.9M
LQDA

LIQUIDIA CORPORATION

$88.8M